Business Wire

Energy Aspects Acquires OilX, a Pioneer in AI Driven Data Analytics for Energy Markets

1.2.2023 11:52:00 CET | Business Wire | Press Release

Share

Leading energy and macro research consultancy Energy Aspects has acquired OilX, a pioneer in AI-driven energy data analytics. The acquisition will enhance Energy Aspects’ insights as OilX’s real-time data technology complements Energy Aspects’ forward-looking analysis. OilX, in turn, will benefit from Energy Aspects’ proprietary data sets and world-class subject matter experts, improving its data-driven insights to clients.

Founded in 2018 by Dr. Florian Thaler, OilX’s unique real-time energy market platform offers sophisticated ‘nowcasting’ capabilities, enabling its clients to understand energy markets as they evolve. OilX’s advanced technology utilises AI, satellite and tanker tracking data to create highly valuable proprietary data sets, and its UX design delivers high data usability.

OilX’s product range covers crude oil, refined products, biofuels and NGL’s. Their platform, the world’s first real-time oil supply and demand balance, provides users with market analysis ahead of official data releases and relative to consensus estimates. Additionally, the company’s WhatsApp bot enables users to receive an instant response to queries about the entire global oil supply/demand balance.

“We are thrilled to welcome OilX to our team and are optimistic about the many opportunities that this acquisition presents”, said Dr. Amrita Sen, co-founder and Director of Research at Energy Aspects. “With OilX becoming part of Energy Aspects, we will be able to deliver to our clients not only leading energy markets forecasting and insights but also the most accurate view of market movements as they happen.”

“I have always admired Energy Aspects as the undisputed industry leader in energy analysis” said Dr. Florian Thaler, CEO of OilX. “We are excited about the opportunity to become part of the Energy Aspects growth story and to combine state-of-the art AI technology with top class analysts to produce the highest quality information for our clients.”

Energy Aspects’ purchase of OilX is part of the company’s ambitious growth plan and follows its 2020 acquisition of Medley Global Advisors, a macro policy research service for hedge funds, asset managers, banks, and institutional investors, and a strategic investment from Summit Partners in 2022. Energy Aspects has a roadmap to integrate the platforms in the short-medium term, allowing for a smooth customer user experience in accessing both offerings.

Energy Aspects was founded in 2012 by energy industry experts Dr. Amrita Sen, Fredrik Fosse, and Richard Bronze to meet the need for timely, independent research that provides deep dives in energy market and macro fundamentals, grounded on robust data and timely forecasts, all while maintaining a commitment to timeliness and precision. Over 500 organisations rely on Energy Aspects’ broad product range covering short-term, long-term, and macro trends, and direct access to analysts for specific queries. It is headquartered in London with additional offices in New York, Houston, Singapore, Tokyo and India.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For further information:
press@energyaspects.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye